Is It Possible to Delay or Prevent Age-Related Cognitive Decline?
Already in the 90s, Khachaturian stated that postponing dementia onset by five years would decrease the prevalence of the late onset dementia by 50%. After two decades of lack of success in dementia drug discovery and development, and knowing that worldwide, currently 36 million patients have been diagnosed with Alzheimer's disease, a number that will double by 2030 and triple by 2050, the World Health Organization and the Alzheimer's Disease International declared that prevention of cognitive decline was a 'public health priority.' Numerous longitudinal studies and meta-analyses were conducted to analyze the risk and protective factors for dementia. Among the 93 identified risk factors, seven major modifiable ones should be considered: low education, sedentary lifestyle, midlife obesity, midlife smoking, hypertension, diabetes, and midlife depression. Three other important modifiable risk factors should also be added to this list: midlife hypercholesterolemia, late life atrial fibrillation, and chronic kidney disease. After their identification, numerous authors attempted to establish dementia risk scores; however, the proposed values were not convincing. Identifying the possible interventions, able to either postpone or delay dementia has been an important challenge. Observational studies focused on a single life-style intervention increased the global optimism concerning these possibilities. However, a recent extensive literature review of the randomized control trials (RCTs) conducted before 2014 yielded negative results. The first results of RCTs of multimodal interventions (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, Multidomain Alzheimer Prevention Study, and Prediva) brought more optimism. Lastly, interventions targeting compounds of beta amyloid started in 2012 and no results have yet been published.
Academic Geriatric Department, Geneva University, Geneva, Switzerland.
Jean-Pierre
JP
Michel
Alzheimer Disease; Brain Reserve; Cognitive Decline; Dementia; Mediterranean Diet; Physical Activity
Int J Clin Pharmacol Res. 1990;10(1-2):3-5
2387662
J Intern Med. 2011 Jan;269(1):107-17
20831630
PLoS One. 2015 Apr 28;10(4):e0123972
25919586
F1000Prime Rep. 2015 May 12;7:50
26097723
PLoS Med. 2006 Oct;3(10):e430
17076560
Ann Neurol. 1997 Nov;42(5):776-82
9392577
Neurology. 2013 Apr 2;80(14):1300-6
23547265
Lancet Neurol. 2014 Aug;13(8):788-94
25030513
J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1299-306
26294005
Lancet. 2015 Jun 6;385(9984):2255-63
25771249
N Engl J Med. 2016 Feb 11;374(6):523-32
26863354
Am J Nephrol. 2012;35(5):474-82
22555151
Lancet Neurol. 2006 Sep;5(9):735-41
16914401
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12 ):1318-25
23670794
Lancet Neurol. 2015 Sep;14(9):926-44
26213339
J Alzheimers Dis. 2014;42(1):183-91
24825565
BMJ. 2001 Jun 16;322(7300):1447-51
11408299
Alzheimers Dement. 2016 Jan;12(1):60-4
26710325
Int J Geriatr Psychiatry. 2015 Mar;30(3):234-46
25504093
Alzheimers Dement. 2014 Sep;10(5):562-70
24035147
N Engl J Med. 2016 Feb 11;374(6):507-9
26863352